{"id":158406,"date":"2023-02-18T10:24:00","date_gmt":"2023-02-18T16:24:00","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2023\/02\/celery-seed-derived-medicine-may-improve-stroke-outcomes"},"modified":"2023-02-18T10:24:00","modified_gmt":"2023-02-18T16:24:00","slug":"celery-seed-derived-medicine-may-improve-stroke-outcomes","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2023\/02\/celery-seed-derived-medicine-may-improve-stroke-outcomes","title":{"rendered":"Celery Seed-Derived Medicine May Improve Stroke Outcomes"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/celery-seed-derived-medicine-may-improve-stroke-outcomes2.jpg\"><\/a><\/p>\n<p>Patients who received the treatment had less severe brain symptoms and better daily functioning 90 days after the stroke, as compared with those who received clot treatment and a placebo medication.<\/p>\n<p>Butylphthalide is approved and available for use in China, where the study was done. But the medication hasn\u2019t been approved for use by the FDA.<\/p>\n<p>\u201cThis is the first trial to show the benefit of using a medication that protects the brain from damage caused by a lack of oxygen to brain tissue. The medication was given to patients with acute ischemic stroke who were also receiving treatment to restore blood flow to the brain,\u201d says co-author Baixue Jia, MD, a doctor of interventional neuroradiology at the Beijing Tiantan Hospital and the China National Clinical Research Center for Neurological Diseases in Beijing.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Patients who received the treatment had less severe brain symptoms and better daily functioning 90 days after the stroke, as compared with those who received clot treatment and a placebo medication. Butylphthalide is approved and available for use in China, where the study was done. But the medication hasn\u2019t been approved for use by the [\u2026]<\/p>\n","protected":false},"author":396,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47],"tags":[],"class_list":["post-158406","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/158406","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/396"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=158406"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/158406\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=158406"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=158406"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=158406"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}